Quality of Life Improvement for Patients with Resistant OCD Using Deep Brain Stimulation
Official title: European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment
Run by University Hospital, Grenoble · NCT02844049 · Data updated 2026-11-12
This study is testing if Deep Brain Stimulation can help people with severe OCD who haven't found relief from other treatments feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 69 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 8 sites (Créteil and 7 other locations) |
| Status | Recruiting |
| Started | September 2016 |
| Main results expected | July 2026 |
| Study ends | April 2027 |
| Registry record updated | November 29, 2023 |
| Trial ID | NCT02844049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with OCD for over five years who have not responded to multiple standard treatments.
✕Probably not a fit
Patients with specific OCD symptoms like hoarding or those with a history of psychosis or severe personality disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of Deep Brain Stimulation (DBS) on patients with Obsessive-Compulsive Disorder (OCD) who have not responded to traditional treatments. It aims to assess not only the clinical improvement in symptoms but also the overall quality of life of participants, which is often overlooked in standard treatment evaluations. The study will also explore potential biomarkers that could predict which patients are most likely to benefit from DBS. By focusing on a larger cohort, the research seeks to validate the effectiveness of this innovative surgical approach in enhancing patients' functional status and well-being.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for patients suffering from treatment-resistant OCD.
How similar studies have gone: Other studies have shown promising results with DBS for OCD, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * OCD for \> 5 years * YBOCS\> 25 and/or YBOCS sub-scale \>15 * GAF\< 45 * 3 or more documented SRI trials, including clomipramine (10-12 weeks at adequate dose) * SRI augmentation for \> 4 weeks with at least one antipsychotic and with one of the following: lithium, clonazepam * Adequate trial of CBT (Exposure Therapy and Response Prevention) (intolerance or \>15 sessions) * Ability to provide informed consent Exclusion Criteria: * Hoarding (if the only OCD symptom) * OCD with poor insight (BABS score \> 12) * Lifetime diagnosis of psychosis or bipolar disorder; * Substance abuse or dependence within the previous six months; * Baseline Montgomery and Asberg (MADRS) suicidality item (item 10) score \>2; * Current DSM-5 personality disorder of Cluster A (e.g., paranoid or schizotypal personality disorder) or B (e.g., borderline or antisocial personality disorder); * Brain pathology, such as moderate or marked cerebral atrophy, stroke, tumor or previous neurosurgical procedures (i.e. capsulotomy etc), history of cognitive impairment and cognitive deterioration (Addenbrooke's Cognitive Examination ACE score of \< 80). * Contra-indications to surgery, anaesthesia, or MRI * compulsory hospitalization/ care; pregnant or nursing patients
Where it's running
-
University Hospital of Grenoble Michallon
Grenoble, France Recruiting -
Chu Nice - Hopital Pasteur
Nice, France Recruiting -
APHP La Pitié Salpêtrière
Paris, France Recruiting -
Ghu Sainte Anne
Paris, France Recruiting -
Universitätsklinikum Köln (AöR)
Cologne, Germany Recruiting -
Djurfeldt
Stockholm, Sweden Recruiting
Show 2 more locations
-
Hôpitaux Universitaires de Genève
Geneva, Switzerland Recruiting -
CHU Henri Mondor
Créteil, France Completed
Study contacts
- Principal investigator: Mircea Polosan, MD PhD — University Hospital, Grenoble
- Study coordinator: Sandra David-tchouda, MD
- Email: SDavidTchouda@chugrenoble.fr
- Phone: +33476767186
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Mindfulness-Based Cognitive Therapy for OCD Delivered Online
This study tests a synchronous online MBCT program for adults with OCD to see if it is acceptable and feasible and to explore links between biological markers, OCD severity, and treatment response.
-
Targeted brain stimulation for OCD: test of tTIS on nucleus accumbens
This study tests whether targeted temporal interference stimulation of the nucleus accumbens can help reduce obsessive-compulsive symptoms in adults with OCD, compared with sham stimulation.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
AttunE LIFU for OCD: a non-invasive brain stimulation study
This trial tests ATTN201, a wearable ultrasound headband, to see if it helps adults with OCD compared to a sham treatment.
-
Combined ERP and Habit Reversal Therapy for Tourettic OCD
This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.